Education
About Us
Working with TipRanks
Follow Us
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 7.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.04M | $ 7.00M | $ 0.00 | $ -1.51M | $ -1.54M |
| Operating Income | $ -90.61M | $ -111.42M | $ -71.16M | $ -54.66M | $ -43.01M |
| EBITDA | $ -81.10M | $ -99.25M | $ -66.03M | $ -52.96M | $ -40.26M |
| Net Income | $ -83.74M | $ -101.87M | $ -68.24M | $ -54.63M | $ -41.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 132.25M | $ 201.37M | $ 276.56M | $ 208.35M | $ 140.45M |
| Total Assets | $ 144.68M | $ 221.24M | $ 299.57M | $ 217.93M | $ 151.84M |
| Total Debt | $ 16.18M | $ 18.93M | $ 21.26M | $ 14.04M | $ 5.46M |
| Net Debt | $ -25.57M | $ -16.56M | $ -19.19M | $ -48.84M | $ -15.76M |
| Total Liabilities | $ 27.77M | $ 33.66M | $ 29.70M | $ 21.06M | $ 10.86M |
| Stockholders' Equity | $ 116.92M | $ 187.57M | $ 269.87M | $ 196.88M | $ 140.98M |
| Cash Flow | |||||
| Free Cash Flow | $ -74.24M | $ -83.45M | $ -60.42M | $ -42.75M | $ -37.14M |
| Operating Cash Flow | $ -74.21M | $ -81.64M | $ -58.85M | $ -42.44M | $ -36.95M |
| Investing Cash Flow | $ 80.43M | $ 76.05M | $ -91.39M | $ -28.44M | $ -56.50M |
| Financing Cash Flow | $ 103.00K | $ 638.00K | $ 127.86M | $ 112.58M | $ 99.64M |